中西医结合治疗晚期非小细胞肺癌患者的效果

Effect of Chinese and western medicine treatment for advanced non-small cell lung cancer patients

  • 摘要:
      目的  评价中西医结合治疗晚期非小细胞肺癌(NSCLC)效果。
      方法  将医院抽取的108例晚期非小细胞肺癌按照1: 1比例配对原则分为2组, 对照组54例采用单纯化疗治疗,观察组54例采用健脾益肾汤联合化疗治疗,比较不同方法的治疗效果。
      结果  观察组中医症候疗效、Karnofsky功能状态(KPS)评分改善有效率高于对照组,免疫功能改善优于对照组,毒副反应发生率低于对照组,差异有统计学意义(P < 0.05)。
      结论  中西医结合治疗晚期非小细胞肺癌可有效改善患者的免疫功能指标以及生活质量。

     

    Abstract:
      Objective  To evaluate effect of traditional Chinese and western medicine treatment for advanced non-small cell lung cancer (NSCLC).
      Methods  A total of 108 advanced non-small cell lung cancer patients in the study were divided into two groups according to the proportion of 1 to 1 matching principle. The control group (n=54) was given pure chemotherapy treatment, while the observation group(n=54) conducted Jianpi Yishen Decoction combined with chemotherapy. Treatment effects of different methods were compared.
      Results  The observation group had higher effectiveness rate in improvement of TCM symptoms, Karnofsky function status (KPS) score than the control group, the improvement of immune function was better, and the incidence of adverse reactions was lower than the control group(P < 0.05).
      Conclusion  Traditional Chinese and western medical treatment for advanced non-small cell lung cancer can effectively improve the patient′s immune function index and quality of life.

     

/

返回文章
返回